title: [Targeting therapy for renal cancer].
abstract: Renal cancer is a typical tumor most insensitive to standard chemotherapy, but this hypervascular tumor has an anatomical feature by which its main feeding artery is readily accessible to transarterial targeting treatments. Effects of arterial chemoembolization, a prototype targeting chemotherapy, on renal cancer were reviewed.
authors.affiliation: Dept. of Urology, Akita University School of Medicine.
authors.forename: T
authors.initials: T
authors.lastname: Kato
authors.forename: K
authors.initials: K
authors.lastname: Sato
authors.forename: H
authors.initials: H
authors.lastname: Kakinuma
mesh_terms: D001918:Brachytherapy; D002292:Carcinoma, Renal Cell / Q000401:mortality / Q000532:radiotherapy / Q000628:therapy*; D016461:Chemoembolization, Therapeutic; D006801:Humans; D007680:Kidney Neoplasms / Q000401:mortality / Q000532:radiotherapy / Q000628:therapy*; D008299:Maleic Anhydrides / Q000008:administration & dosage; D016685:Mitomycin / Q000008:administration & dosage; D011137:Polystyrenes / Q000008:administration & dosage; D015996:Survival Rate; D009353:Zinostatin / Q000008:administration & dosage / Q000031:analogs & derivatives
chemical_list: D008299:Maleic Anhydrides; D011137:Polystyrenes; C035755:poly(maleic acid-styrene)neocarzinostatin; D016685:Mitomycin; D009353:Zinostatin